Related Experiment Video
Updated: Oct 16, 2025

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent
Víctor D Cuevas1, Miriam Simón-Fuentes1, Emmanuel Orta-Zavalza1
1Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.
Abstract:
During inflammatory responses, monocytes are recruited into inflamed tissues, where they become monocyte-derived macrophages and acquire pro-inflammatory and tissue-damaging effects in response to the surrounding environment. In fact, monocyte-derived macrophage subsets are major pathogenic cells in inflammatory pathologies. Strikingly, the transcriptome of pathogenic monocyte-derived macrophage subsets resembles the gene profile of macrophage colony-stimulating factor (M-CSF)-primed monocyte-derived human macrophages (M-MØ). As M-MØ display a characteristic cytokine profile after activation (IL10high TNFlow IL23low IL6low), we sought to determine the transcriptional signature of M-MØ upon exposure to pathogenic stimuli. Activation of M-MØ led to the acquisition of a distinctive transcriptional profile characterized by the induction of a group of genes (Gene set 1) highly expressed by pathogenic monocyte-derived macrophages in COVID-19 and whose presence in tumor-associated macrophages (TAM) correlates with the expression of macrophage-specific markers (CD163, SPI1) and IL10. Indeed, Gene set 1 expression was primarily dependent on ERK/p38 and STAT3 activation, and transcriptional analysis and neutralization experiments revealed that IL-10 is not only required for the expression of a subset of genes within Gene set 1 but also significantly contributes to the idiosyncratic gene signature of activated M-MØ. Our results indicate that activation of M-CSF-dependent monocyte-derived macrophages induces a distinctive gene expression profile, which is partially dependent on IL-10, and identifies a gene set potentially helpful for macrophage-centered therapeutic strategies.
Insights
Monocyte-derived macrophages (M-MØ) activated by macrophage colony-stimulating factor (M-CSF) develop a unique gene signature. This signature, partly driven by IL-10, may offer targets for new macrophage-centered therapies.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Monocytes infiltrate inflamed tissues, differentiating into pro-inflammatory monocyte-derived macrophages (MDMs) that drive pathology.
- Pathogenic MDM subsets share transcriptional similarities with M-CSF-primed human macrophages (M-MØ).
- M-MØ exhibit a distinct cytokine profile (IL10high, TFNlow, IL23low, IL6low) upon activation.
Purpose of the Study:
- To elucidate the transcriptional signature of M-MØ upon stimulation with pathogenic factors.
- To identify key signaling pathways and molecular players involved in M-MØ activation.
- To explore the potential of M-MØ-associated gene sets for therapeutic strategies.
Main Methods:
- Transcriptome analysis of activated M-MØ.
- Investigation of signaling pathways including ERK/p38 and STAT3.
- Gene set enrichment analysis and correlation with pathogenic macrophage markers (CD163, SPI1).
- IL-10 neutralization experiments.
Main Results:
- M-MØ activation induced a specific transcriptional profile (Gene set 1) linked to pathogenic macrophages in COVID-19 and TAMs.
- Gene set 1 expression was dependent on ERK/p38 and STAT3 activation.
- IL-10 was essential for a subset of Gene set 1 genes and contributed to the overall M-MØ signature.
Conclusions:
- M-CSF-primed human macrophages acquire a distinctive gene expression profile upon activation.
- This profile is partially regulated by IL-10 and involves ERK/p38 and STAT3 signaling.
- The identified gene set holds potential for developing novel macrophage-targeted therapies.

